Ingredion
INGR
$100.81
-0.69%
Ingredion Incorporated is a global ingredients provider that processes corn, tapioca, potatoes, stevia, grains, and other raw materials into value-added ingredients for the food, beverage, brewing, and animal nutrition industries. The company operates as a significant player in the packaged foods sector, distinguishing itself through a dual portfolio of higher-margin specialty ingredients, like starch-based texturizers and stevia sweeteners, and commodity ingredients such as high-fructose corn syrup. The current investor narrative is dominated by the company's strategic ambition to consolidate its market position, as evidenced by the recent announcement of a recommended all-cash acquisition of Tate & Lyle, a move aimed at dominating the specialty ingredients space and driving future growth through synergies. This transformative deal is the central focus, sparking debate on integration risks, debt financing implications, and the potential for accelerated margin expansion against a backdrop of potential consumer demand volatility.…
INGR
Ingredion
$100.81
Related headlines
Investment Opinion: Should I buy INGR Today?
Rating: Hold. The core thesis is that INGR presents a classic 'value trap' scenario—deeply undervalued on paper but lacking a near-term catalyst to reverse its powerful downtrend, with significant execution risk overshadowing its strategic ambitions.
The stock's valuation is undeniably low, with a trailing P/E of 9.71x, a P/S of 0.98x, and an EV/EBITDA of 6.36x, suggesting a substantial margin of safety if fundamentals stabilize. A strong ROE of 16.8% and a healthy current ratio of 2.66 indicate underlying business quality. However, these metrics are counteracted by a -27.1% one-year price decline, a -9.6% three-month decline, and the absence of a clear analyst price target to define upside potential.
The thesis would upgrade to a Buy if the stock convincingly holds above its 52-week low and shows technical stabilization, or if early integration updates on the Tate & Lyle deal are positive and debt remains manageable. It would downgrade to a Sell on a breakdown below the $97.12 support level or signs of acquisition-related financial strain. Relative to its own depressed price history, the stock is fairly valued for the elevated risk it carries, but it is likely undervalued relative to its long-term earnings power if the acquisition succeeds.
Sign up to view all
INGR 12-Month Price Forecast
The outlook for INGR is a binary bet on the success of its major acquisition. The current low valuation prices in significant skepticism, offering a margin of safety, but the persistent downtrend cannot be ignored. The most likely path (Base Case, 55% probability) is a period of volatile sideways action as the market digests deal developments. The stance would upgrade to Bullish on evidence of successful integration and technical reversal above key resistance levels. It would turn Bearish on a breakdown below $97.12 or clear signs of acquisition value destruction.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ingredion's 12-month outlook, with a consensus price target around $131.05 and implied upside of +30.0% versus the current price.
Average Target
$131.05
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$81 - $131
Analyst target range
Analyst coverage for Ingredion appears limited, with data indicating only 3 analysts providing estimates; the consensus recommendation and average target price are not provided, preventing a calculation of implied upside or downside from the current price. The provided data shows a tight range for estimated EPS (high: $12.52, low: $12.28) and revenue (high: $7.77B, low: $7.75B) for the upcoming period, signaling strong analyst conviction on near-term financial outcomes but offering no view on the stock's price trajectory. The absence of institutional ratings or price targets suggests limited sell-side coverage, which is common for mid-cap stocks and can lead to higher volatility and less efficient price discovery, especially during a major corporate event like the Tate & Lyle acquisition.
Bulls vs Bears: INGR Investment Factors
The investment debate for Ingredion is sharply divided between a compelling value proposition and severe technical and execution risks. The bear case currently holds stronger evidence, as reflected in the stock's persistent 27% annual decline and proximity to its 52-week low, which directly quantifies market skepticism. The single most important tension is the successful integration and financing of the Tate & Lyle acquisition. If executed flawlessly, it validates the bull thesis of margin expansion and market dominance, justifying the low valuation. If integration stumbles or debt balloons, it confirms the bear thesis of value destruction, likely pushing the stock toward and below its recent lows.
Bullish
- Deeply Discounted Valuation: The stock trades at a trailing P/E of 9.71x and a forward P/E of 8.75x, which appears low on an absolute basis. Combined with a Price-to-Sales ratio of 0.98x, this suggests the market may be undervaluing the company's earnings power and assets, especially given its 16.8% ROE.
- Strong Balance Sheet & Liquidity: A Debt-to-Equity ratio of 0.41 indicates a conservatively leveraged capital structure, providing significant financial flexibility. A Current Ratio of 2.66 demonstrates robust short-term liquidity, which is crucial for navigating market volatility and funding strategic initiatives like the Tate & Lyle acquisition.
- Transformative Acquisition Potential: The recommended all-cash acquisition of Tate & Lyle is a major strategic move to dominate the higher-margin specialty ingredients market. If successfully integrated, it promises significant growth and cost synergies, potentially accelerating margin expansion from the current operating margin of 14.4%.
- Attractive Dividend Yield: The stock offers a dividend yield of approximately 2.98%, supported by a sustainable payout ratio of 28.9%. This provides a tangible return to shareholders while they wait for the strategic acquisition thesis to play out, offering a margin of safety in a downtrend.
Bearish
- Severe Technical Downtrend: The stock is in a pronounced downtrend, down 27.1% over the past year and 9.6% over the past three months, severely underperforming the S&P 500. Trading at $101.59, it is only 8% above its 52-week low of $97.12, signaling persistent selling pressure and a lack of near-term catalysts.
- Acquisition Execution & Debt Risk: The all-cash acquisition of Tate & Lyle introduces significant integration and execution risk. While the current D/E is low, financing a major deal could materially increase leverage, burden the balance sheet, and divert cash flow from shareholders, creating uncertainty that is currently depressing the stock price.
- Weak Profitability Margins: The company's gross margin of 25.3% and operating margin of 14.4% appear relatively thin for an ingredients provider, potentially indicating pricing pressure in commodity segments or high input costs. Without trend data, the durability of the 10.1% net margin is uncertain.
- Limited Analyst Coverage & Visibility: With only 3 analysts providing estimates and no consensus price target available, there is limited institutional guidance and potentially inefficient price discovery. This can lead to higher volatility, as seen in the stock's 29.4% max drawdown, and makes it harder for investors to gauge fair value.
INGR Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -27.14%, significantly underperforming the broader market. Currently trading at a price of $101.59, it sits near the lower end of its 52-week range of $97.12 to $140.47, positioning it at approximately 8% above the 52-week low, which suggests the market is pricing in substantial fundamental concerns or a value opportunity, albeit with high risk of further downside. The short-term momentum is also negative and accelerating, with a 1-month decline of -4.15% and a 3-month decline of -9.56%, both diverging sharply from the S&P 500's positive returns over the same periods, indicating severe stock-specific weakness and a lack of near-term catalysts to arrest the slide. Key technical support is clearly defined at the 52-week low of $97.12, while resistance lies at the 52-week high of $140.47; a decisive breakdown below $97.12 would signal a continuation of the bearish trend, whereas a recovery would need to reclaim higher levels. The stock's beta of 0.595 indicates it is approximately 40% less volatile than the SPY, which is atypical for a stock in such a steep decline and suggests its moves are driven more by idiosyncratic factors than broad market sentiment, impacting risk assessment for portfolio construction.
Beta
0.59
0.59x market volatility
Max Drawdown
-29.4%
Largest decline past year
52-Week Range
$97-$140
Price range past year
Annual Return
-26.8%
Cumulative gain past year
| Period | INGR Return | S&P 500 |
|---|---|---|
| 1m | -1.8% | +1.5% |
| 3m | -9.5% | +13.4% |
| 6m | -9.4% | +10.9% |
| 1y | -26.8% | +24.5% |
| ytd | -8.2% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
INGR Fundamental Analysis
Data not available for a detailed quarterly revenue trajectory, YoY growth rates, or segment performance, preventing a granular analysis of the company's growth drivers. Data not available for net income, gross margin trends over recent quarters, or a comparison to industry typical margins, hindering an assessment of profitability and margin health. Data not available for free cash flow, detailed debt ratios beyond the provided D/E, or return on equity figures beyond the single point-in-time metric, limiting a comprehensive evaluation of balance sheet strength and cash flow sustainability. The provided data points, such as a Debt-to-Equity ratio of 0.41 and a Current Ratio of 2.66, suggest a conservatively leveraged company with strong short-term liquidity, while an ROE of 16.8% indicates decent returns on shareholder equity, but without trend data, the durability of these metrics cannot be confirmed.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is INGR Overvalued?
Given that the trailing Net Margin is positive at 10.1%, implying positive net income, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 9.71x and a forward P/E of 8.75x; the lower forward multiple suggests the market anticipates modest earnings growth or a potential compression, aligning with the current negative price momentum. A direct peer comparison is not possible as industry average multiples were not provided in the data; however, the stock's P/E of 9.71x and Price-to-Sales (P/S) ratio of 0.98x appear low on an absolute basis, potentially indicating a discount if future growth prospects are underappreciated. Historical context for the valuation is unavailable as historical ratio data was not provided, making it impossible to determine if the current P/E of 9.71x is near the top or bottom of its own historical range, which is a critical gap in assessing whether the stock is cheap or appropriately priced for its fundamentals.
PE
9.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the transformative Tate & Lyle acquisition. While the current Debt-to-Equity of 0.41 is low, an all-cash deal will likely require significant new debt or cash reserves, increasing leverage and financial risk. The company's gross margin of 25.3% is not exceptionally high, and without detailed quarterly data, there is uncertainty around margin sustainability and the company's ability to achieve projected synergies from the deal. The low analyst coverage (only 3 analysts) further obscures financial visibility and increases the risk of earnings surprises.
Market & Competitive Risks are heightened by the stock's valuation context. Trading at a forward P/E of 8.75x, the market is assigning a deep discount, likely due to concerns over execution and sector headwinds. The stock's beta of 0.595 suggests it is less correlated to the market, but its 50 percentage point underperformance versus the S&P 500 over the past year indicates severe stock-specific de-rating. Competitive pressures in both specialty and commodity ingredients, along with potential consumer demand volatility, pose ongoing threats to revenue and pricing power.
The Worst-Case Scenario involves a botched integration of Tate & Lyle, where anticipated synergies fail to materialize, debt costs rise, and the combined entity faces market share erosion. This could trigger further analyst disengagement and sustained selling. The realistic downside is quantified by the 52-week low of $97.12, representing a -4.4% decline from the current price of $101.59. A more severe scenario could see the stock test levels implied by the maximum drawdown of -29.4%, which from the 52-week high of $140.47 suggests a price near $99.20, indicating potential for a further -2.4% drop to that psychological level.
FAQ
The key risks are, in order of severity: 1) Acquisition Execution Risk: The all-cash Tate & Lyle deal carries major integration and financing uncertainties that could destroy value. 2) Technical & Sentiment Risk: The stock is in a powerful downtrend, down 27.1% over the past year, and breaking below the $97.12 support could trigger further selling. 3) Financial Risk: While current leverage is low, funding the acquisition may increase debt and interest costs, pressuring cash flow. 4) Market Risk: As a packaged food company, it is exposed to consumer demand volatility and input cost inflation, which could pressure its 25.3% gross margin.
The 12-month forecast is bifurcated around the Tate & Lyle acquisition outcome. The Base Case (55% probability) sees the stock trading between $105 and $120 as integration proceeds without major hiccups. The Bull Case (25% probability) targets $125 to $140 on successful execution and valuation re-rating. The Bear Case (20% probability) warns of a drop to $90-$97 if integration fails and the downtrend accelerates. The most likely scenario is sideways consolidation with high volatility, as the market demands proof that the strategic deal will create shareholder value.
INGR appears significantly undervalued based on traditional multiples. It trades at a forward P/E of 8.75x, a P/S of 0.98x, and an EV/EBITDA of 6.36x, which are low on an absolute basis and suggest the market is pricing in substantial risk. Compared to its own 52-week high of $140.47, the current price of $101.59 represents a 28% discount. The valuation implies the market expects minimal growth, significant execution missteps from the acquisition, or both. If the company executes well, the current price could prove to be a deep discount.
INGR is a high-risk, high-potential-reward stock that may be a good buy only for specific investors. Its deep value metrics (P/E of 8.75x forward) and strong balance sheet (D/E of 0.41) are attractive, offering a significant margin of safety. However, the stock is in a severe downtrend (-27.1% over 1 year) with the major overhang of integrating the Tate & Lyle acquisition. It is a good buy for patient, value-oriented investors who believe in management's acquisition strategy and can withstand further near-term volatility. It is not suitable for short-term traders or risk-averse investors.
INGR is unequivocally a long-term investment, with a suggested minimum holding period of 2-3 years. The entire investment thesis hinges on the multi-year process of integrating Tate & Lyle, realizing synergies, and improving the margin profile. The stock's low beta of 0.595 and 2.98% dividend yield support a long-term holding strategy by providing some stability and income. It is poorly suited for short-term trading due to its severe negative momentum, lack of near-term catalysts, and the high likelihood of continued volatility driven by acquisition-related news flow.